Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients
- PMID: 17617762
- PMCID: PMC8109936
- DOI: 10.1111/j.1524-6175.2007.06672.x
Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients
Abstract
The authors examined the relationship of clinic and self-measured pulse pressure with target organ damage in 597 treated hypertensive patients without clinical evidence of renal dysfunction or a history of heart failure. The cross-sectional relationships of plasma brain natriuretic peptide (BNP) and urinary albumin/creatinine ratio with clinic and self-monitored pulse pressures were estimated in age tertile groups: younger than 67 years (n=193), 67 to 75 years (n=216), and older than 75 years (n=188), controlling for various confounding factors. In multivariable analyses, both clinic and self-monitored higher pulse pressures were associated with increased urinary albumin/creatinine ratio in all 3 age groups. Self-monitored higher pulse pressure, but not clinic pulse pressure, was consistently associated with increased BNP in the younger and middle-aged patients. In the very old (older than 75 years), however, there were no consistent associations between pulse pressure measures and BNP. More studies are needed in the evaluation of cardiac risk with hemodynamic measures in the very old.
Similar articles
-
Changes in self-monitored pulse pressure correlate with improvements in B-type natriuretic Peptide and urinary albumin in treated hypertensive patients.Am J Hypertens. 2007 Dec;20(12):1268-75. doi: 10.1016/j.amjhyper.2007.08.012. Am J Hypertens. 2007. PMID: 18047916
-
Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.Hypertens Res. 2008 May;31(5):887-96. doi: 10.1291/hypres.31.887. Hypertens Res. 2008. PMID: 18712044 Clinical Trial.
-
Central pulse pressure links microalbuminuria with plasma B-type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension.J Hypertens. 2014 Aug;32(8):1665-71; discussion 1671. doi: 10.1097/HJH.0000000000000242. J Hypertens. 2014. PMID: 24906172
-
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Adv Exp Med Biol. 2017. PMID: 27873229 Review.
-
You can do more to slow the progression of heart failure.J Fam Pract. 2009 Mar;58(3):122-8. J Fam Pract. 2009. PMID: 19284937 Free PMC article. Review. No abstract available.
Cited by
-
Single-pill combination of cilnidipine, an L-/N-type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE-Combi survey.J Clin Hypertens (Greenwich). 2020 Mar;22(3):457-464. doi: 10.1111/jch.13771. J Clin Hypertens (Greenwich). 2020. PMID: 32311215 Free PMC article.
References
-
- Benetos A, Safar M, Rudnichi A, et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1997;30:1410–1415. - PubMed
-
- Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? the Framingham Heart Study. Circulation. 2001;103:1245–1249. - PubMed
-
- Madhavan S, Ooi W, Cohen H, et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395–401. - PubMed
-
- Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens. 1999;17:1065–1072. - PubMed
-
- Fang J, Madhavan S, Cohen H, et al. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens. 1995;13:413–419. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical